Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆.
Ann Oncol. 2021 Apr;32(4):533-541. doi: 10.1016/j.annonc.2021.01.004. Epub 2021 Jan 19.
Ann Oncol. 2021.
PMID: 33482247
Free article.
Clinical Trial.
Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications.
Romero I, Leskelä S, Mies BP, Velasco AP, Palacios J.
Romero I, et al. Among authors: velasco ap.
EJC Suppl. 2020 Aug 22;15:1-15. doi: 10.1016/j.ejcsup.2020.02.001. eCollection 2020 Aug.
EJC Suppl. 2020.
PMID: 33240438
Free PMC article.
Item in Clipboard
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Vergote I, Scambia G, O'Malley DM, Van Calster B, Park SY, Del Campo JM, Meier W, Bamias A, Colombo N, Wenham RM, Covens A, Marth C, Raza Mirza M, Kroep JR, Ma H, Pickett CA, Monk BJ; TRINOVA-3/ENGOT-ov2/GOG-3001 investigators.
Vergote I, et al.
Lancet Oncol. 2019 Jun;20(6):862-876. doi: 10.1016/S1470-2045(19)30178-0. Epub 2019 May 7.
Lancet Oncol. 2019.
PMID: 31076365
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite